Biolimus A9-eluting stent vs a bare metal stent in patients with coronary artery disease

Trial Profile

Biolimus A9-eluting stent vs a bare metal stent in patients with coronary artery disease

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 02 Dec 2011

At a glance

  • Drugs Umirolimus (Primary)
  • Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
  • Focus Therapeutic Use
  • Acronyms STEALTH; STEALTH-I
  • Most Recent Events

    • 11 Nov 2011 Five-year results presented at the 23rd Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics.
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top